Insider Trading History of Williams Douglas E

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Williams Douglas E since 2007. This trader's CIK number is 1184847. At the time of last reporting, Williams Douglas E was the President & CEO of Codiak Biosciences, Inc.. (stock ticker symbol CDAK). Also see all insider trading activities at Codiak Biosciences, Inc..

Note that in the past WILLIAMS DOUGLAS E also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Anadys Pharmaceuticals Inc (ANDS) by Williams Douglas E

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 ANDS 2,000 $4,720 0 $0 0 $0

Yearly summary of insider trading at Biogen Inc. (BIIB) by Williams Douglas E

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 BIIB 0 $0 3,841 $1,574,810 13,825 $0
2014 BIIB 0 $0 3,505 $1,234,776 12,200 $0
2013 BIIB 0 $0 4,368 $923,168 8,165 $0
2012 BIIB 0 $0 0 $0 5,159 $0

Yearly summary of insider trading at Codiak Biosciences, Inc. (CDAK) by Williams Douglas E

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 CDAK 0 $0 56,460 $27,785 45,938 $0

Yearly summary of insider trading at Array Biopharma Inc (ARRY) by Williams Douglas E

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 ARRY 2,500 $15,400 0 $0 0 $0

Yearly summary of insider trading at Ovid Therapeutics Inc. (OVID) by Williams Douglas E

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 OVID 5,000 $32,440 0 $0 0 $0

Yearly summary of insider trading at Zymogenetics Inc (ZGEN) by Williams Douglas E

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 ZGEN 2,000 $24,500 0 $0 0 $0


Insider trading activities at 6 companies by Williams Douglas E:

1. Anadys Pharmaceuticals Inc (ANDS)

2. Biogen Inc. (BIIB)

3. Codiak Biosciences, Inc. (CDAK)

4. Array Biopharma Inc (ARRY)

5. Ovid Therapeutics Inc. (OVID)

6. Zymogenetics Inc (ZGEN)

Table 1. Insider trading of Anadys Pharmaceuticals Inc (ANDS) by Williams Douglas E

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-09-04 ANDS Buy 2,000 2.36 4,720

Table 2. Insider trading of Biogen Inc. (BIIB) by Williams Douglas E

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-06-19 BIIB Sale 3,841 410.00 1,574,810
2015-02-12 BIIB Option Ex 5,200 .00 0
2015-02-08 BIIB Option Ex 3,468 .00 0
2015-02-01 BIIB Option Ex 5,157 .00 0
2014-03-19 BIIB Sale 3,505 352.29 1,234,776
2014-02-12 BIIB Option Ex 3,573 .00 0
2014-02-08 BIIB Option Ex 3,468 .00 0
2014-02-01 BIIB Option Ex 5,159 .00 0
2013-08-26 BIIB Sale 4,368 211.35 923,168
2013-02-08 BIIB Option Ex 3,006 .00 0
2013-02-01 BIIB Option Ex 5,159 .00 0
2012-02-01 BIIB Option Ex 5,159 .00 0

Table 3. Insider trading of Codiak Biosciences, Inc. (CDAK) by Williams Douglas E

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-03-28 CDAK Sale 41,667 .18 7,500
2022-08-16 CDAK Option Ex 22,969 .00 0
2023-02-16 CDAK Option Ex 22,969 .00 0
2022-08-17 CDAK Sale 7,112 2.21 15,738
2023-02-17 CDAK Sale 7,681 .59 4,547

Table 4. Insider trading of Array Biopharma Inc (ARRY) by Williams Douglas E

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-03-06 ARRY Buy 2,500 6.16 15,400

Table 5. Insider trading of Ovid Therapeutics Inc. (OVID) by Williams Douglas E

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-08-14 OVID Buy 5,000 6.49 32,440

Table 6. Insider trading of Zymogenetics Inc (ZGEN) by Williams Douglas E

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-09-04 ZGEN Buy 2,000 12.25 24,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Williams Douglas E (President & CEO of Codiak Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.